Upcoming Login Downtime
We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.
For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.
Interim data from an open-label, dose-escalation, U.S. Phase I trial in 19 evaluable patients showed that HGS-ETR2 was well tolerated at doses up to 3 mg/kg and maximum tolerated dose had not been rea...
